BUBS Australia Ltd (ASX: BUB) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

BUBS Australia Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $93.88 million
P/E Ratio 25.00
Dividend Yield 0.00%
Shares Outstanding 894.13 million
Earnings per share 0.004
Dividend per share N/A
Year To Date Return -23.64%
Earnings Yield 4.00%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

BUBS Australia Ltd (ASX: BUB)
Latest News

a woman
⏸️ Investing

Cann Group Ltd is one of 64 new shares added to the All Ordinaries this quarter

Cann Group Ltd (ASX:CAN) shares are one of 64 new additions to the All Ordinaries (Index:^AXAO) (ASX:XAO) this month. Here's…

Read more »

a woman
⏸️ Investing

3 speculative shares to watch closely

Bubs Australia Ltd (ASX:BUB) is one of three speculative shares that I think investors ought to keep an eye on.…

Read more »

a woman
⏸️ Investing

Bubs Australia Ltd shares are down 14% in a week

The Bubs Australia Ltd (ASX:BUB) share price has fallen 14% since this time last week. Here's why…

Read more »

a woman
⏸️ Investing

3 tips to avoid the next Big Un Ltd and GetSwift Ltd disasters

Big Un Ltd (ASX:BIG) and GetSwift Ltd (ASX:GSW) have put other high flying small caps with no to low profits…

Read more »

a woman
⏸️ Investing

Is Jatenergy Ltd the next A2 Milk Company Ltd?

Will Jatenergy Ltd (ASX:JAT) be able to follow in the footsteps of infant formula giant A2 Milk Company Ltd (ASX:…

Read more »

a woman
⏸️ Investing

ALL ORDINARIES finishes lower Wednesday: 8 shares you missed

The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished lower on Wednesday.

Read more »

a woman
⏸️ Investing

Why Wattle Health Australia Ltd shares have been smashed today

The Wattle Health Australia Ltd (ASX:WHA) share price has been smashed today after a disappointing half-year result…

Read more »

a woman
⏸️ Investing

Bubs Australia Ltd shares sink lower on weak half-year result

The Bubs Australia Ltd (ASX:BUB) share price has sunk 7% lower after the release of a weak half-year result…

Read more »

a woman
⏸️ Investing

Why these 4 ASX shares are sinking lower today

The Orocobre Limited (ASX:ORE) share price is one of four sinking lower on Tuesday. Here's what you need to know...

Read more »

a woman
⏸️ Investing

The Bubs Australia Ltd share price is going nuts

The Bubs Australia Ltd (ASX:BUB) share price is up 40% since this time last week. Here's what you need to…

Read more »

a woman
⏸️ Investing

What to watch on the ASX this week

The shares of Ramsay Health Care Limited (ASX:RHC), Bubs Australia Ltd (ASX:BUB), and QBE Insurance Group Ltd (ASX:QBE) will be…

Read more »

a woman
⏸️ Investing

Why these 4 ASX shares stormed higher today

The Altium Limited (ASX:ALU) share price is one of four storming higher on Tuesday. Here's why…

Read more »

Frequently Asked Questions

No, Bubs Australia does not pay dividends at this stage.

Bubs Australia Ltd listed on the ASX on 5 October 1993.

BUB ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About BUBS Australia Ltd

Bubs Australia Ltd (ASX: BUB) is a producer of infant nutrition products. The company offers a range of infant formulas including organic grass-fed cows' milk and goat milk products, as well as organic baby food, nutritional supplements, and cereals.

Bubs Australia is also a major Australian supplier of goat milk and goat milk powder for both the infant and adult markets.

The company's products are widely sold in supermarkets and pharmacies in Australia and exported to China, Southeast Asia, and the Middle East. 

BUB Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
10 Apr 2026 $0.11 $0.00 0.00% 187,879 $0.11 $0.11 $0.11
09 Apr 2026 $0.11 $0.00 0.00% 62,881 $0.11 $0.11 $0.11
08 Apr 2026 $0.11 $0.00 0.00% 854,759 $0.11 $0.11 $0.11
07 Apr 2026 $0.11 $-0.01 -9.09% 190,679 $0.11 $0.11 $0.11
02 Apr 2026 $0.11 $0.01 10.00% 1,440,933 $0.10 $0.11 $0.10
01 Apr 2026 $0.10 $0.00 0.00% 1,600,511 $0.11 $0.11 $0.10
31 Mar 2026 $0.11 $0.00 0.00% 948,741 $0.10 $0.11 $0.10
30 Mar 2026 $0.10 $0.00 0.00% 1,249,018 $0.10 $0.11 $0.10
27 Mar 2026 $0.10 $0.00 0.00% 4,949,968 $0.11 $0.11 $0.10
26 Mar 2026 $0.11 $0.00 0.00% 3,407,852 $0.11 $0.11 $0.10
25 Mar 2026 $0.11 $0.00 0.00% 1,898,345 $0.11 $0.11 $0.11
24 Mar 2026 $0.11 $-0.01 -9.09% 334,249 $0.11 $0.11 $0.11
23 Mar 2026 $0.11 $0.00 0.00% 987,739 $0.11 $0.11 $0.11
20 Mar 2026 $0.11 $-0.01 -8.70% 1,355,821 $0.11 $0.11 $0.11
19 Mar 2026 $0.12 $0.00 0.00% 266,829 $0.11 $0.12 $0.11
18 Mar 2026 $0.12 $0.00 0.00% 2,523,925 $0.12 $0.12 $0.11
17 Mar 2026 $0.12 $0.00 0.00% 2,406,883 $0.12 $0.12 $0.12
16 Mar 2026 $0.12 $0.00 0.00% 176,004 $0.12 $0.12 $0.12
13 Mar 2026 $0.12 $0.00 0.00% 967,140 $0.12 $0.12 $0.12
12 Mar 2026 $0.12 $-0.01 -8.00% 1,179,358 $0.12 $0.12 $0.12

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
17 Mar 2026 Paul Jensen Buy 250,000 $28,750
On-market trade.
03 Mar 2026 Paul Jensen Buy 75,156 $9,018
On-market trade.
02 Mar 2026 Paul Jensen Buy 674,844 $80,981
On-market trade.
21 Nov 2025 Joe Coote Issued 7,132,645 $998,570
Issue of securities. 7,132,645 Performance Rights
17 Sep 2025 Paul Jensen Buy 130,890 $18,979
On-market trade.
15 Sep 2025 Paul Jensen Buy 500,000 $81,000
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Paul David Kristian Jensen Non-Executive DirectorNon-Executive Chairman Mar 2023
Mr Jensen brings perspectives drawn from his professional career. Paul is based in Sydney, Australia. Paul has more than 20 years of Board experience as a professional director with both ASX listed, public and private corporations across consumer goods, equity capital markets, banking, government, philanthropy, and indigenous affairs. He brings an international perspective gained from an executive career working in New Zealand, Australia, and the United Kingdom. He currently holds the position of Non-Executive Director and Treasurer for the Australia Made Campaign Limited, which on behalf of the Australian Government administers the highly recognized and trusted Australian Made and ReMade in Australia trademarks, he is a Director of Alterra Limited and GNS Wholesale Limited. Paul is a Fellow of The Australian Institute of Company Directors. He is Chair of the Risk Committee .
Mr Steve Lin Non-Executive Director Apr 2019
Mr Lin currently serves on the Board of three North American consumer products companies, Stella & Chewy's, a pet food company in the US, Petcurean a pet food company in Canada and China and KDC/ONE, OEM/ ODM manufacturers in beauty, personal care and home care. A highly experienced board director, Steve has been doing business in China for 30 years including serving on company and university boards. Steve also has more than 25 years of investment, operations, and management experience in Asia and the US. For the last 7 years Steve has been Managing Partner for C2 Capital, a private equity firm focused on investing in leading consumer products to provide growth capital to scale in the China market. Prior to joining C2 Capital, Steve worked for Morgan Stanley, Goldman Sachs, GMAC Commercial Holding Corp (subsequently, Capmark Financial Group) and Laureate Education in New York, Hong Kong and Tokyo. Steve co-founded a non-profit organization, Hands On Tokyo, and previously served on the Board of Directors of Xi'an Jiaotong-Liverpool University and Hunan International Economics University.
Mr Joe Coote Chief Executive OfficerManaging Director Jul 2025
Mr Coote is an international executive with over 20 years of leadership in the FMCG, dairy and infant nutrition sectors. Most recently he was the CEO of Darigold. Prior to that Mr Coote spent 12 years at Fonterra in senior roles commercial operations across the USA, Asia, and ANZ culminating in President, Fonterra Americas.
Mr Peter Cope General CounselCompany Secretary Jan 2025
-
Naomi Verloop Chief Financial Officer
-
Richard Paine Chief Operating Officer
-
Peter Cope General CounselCompany Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
C2 Capital Global Export-To-China Fund 76,288,510 8.54%
Ataturk Investments Pty Ltd 37,758,682 4.23%
HSBC Custody Nominees (Australia) Limited 30,607,079 3.43%
Citicorp Nominees Pty Limited 26,964,550 3.02%
J P Morgan Nominees Australia Pty Limited 19,044,000 2.13%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 16,996,027 1.90%
Mr Jianlin Zhou 7,058,000 0.79%
Mr Benjamin Paul Landon 7,001,271 0.78%
Boom Securities (Hk) Limited <Clients Account> 6,732,561 0.75%
Keong Lim Pty Limited <Sk Lim Family A/C> 5,346,000 0.60%
Costa Asset Management Pty Ltd <Costa Asset Mgmt Unit A/C> 5,200,000 0.58%
BNP Paribas Nominees Pty Ltd <Clearstream> 4,778,012 0.53%
Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> 4,674,559 0.52%
Stable Charter Limited 4,615,385 0.52%
Mr Xin Fan 4,400,000 0.49%
Ms Liying Wang 4,200,000 0.47%
Mr Jun Hua Chen 4,000,000 0.45%
Intercontinental Pty Limited 4,000,000 0.45%
Ms Zhaochu Yuan 3,982,846 0.45%
Mr Xi Liu 3,977,363 0.45%

Profile

since

Note